Patent details
93093 Product Name: "nécitumumab et ses dérivés pharmaceutiquement acceptables (PORTRAZZA)"
Basic Information
- Publication number:
- 93093
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP057323834
- Legal Status:
- Invalid
- Application number:
- 93093
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1084 - Portrazza - nécitumumab
- Marketing Authorization Type:
- Marketing Authorization Date:
- 18/02/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 31/05/2016
- First Marketing Authorization date:
- 18/02/2016
- Grant date:
- 01/08/2016
- Activation date:
- Publication date:
- 01/08/2016
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 21/03/2030
- SPC Extension Expiration:
- 21/03/2030
- Rejection date:
- Withdrawal date:
Owner
- From:
- 31/05/2016
- Name:
- Imclone LLC
- Address:
- 180 Varick Street, New York, NY 10014, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 31/05/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ZHU Zhenping
- Address:
- United States (US)
2
- Name:
- LIU Meilin
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|